Fundraising Fox

Antares Therapeutics

Boston, US · Founded 2025 · Delaware corporation · 6 known investors

Biotech

Founders & leadership

AF
Andrew FedderExecutive
AF
Adam FriedmanExecutive
BP
Brian PiperExecutive

Investors · 6

Tenmile
AbingworthreportedLondon · $15M – $30M
Atlas Venturereported · 2 sourcesCambridge · $500K – $1Mvia Jean-François Formela · board
Biotechnology Value FundreportedSan Francisco
Lightspeed Venture PartnersreportedMenlo Park · $1.7M – $87M
Vida VenturesreportedLos Angeles

Reported raises · per SEC filings

Form D private placements

$70M disclosed across 2 rounds · 2025

▶$30MraisedMay 2025 · 35 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew FedderExecutive Officer
  • Menelas N. PangalosDirector
  • Jeffrey AlbersDirector
  • Keith FlahertyDirector
  • Jean-Francois FormelaDirector
  • Adam FriedmanExecutive Officer, Director
  • Brian PiperExecutive Officer
  • Shelley ChuDirector
Offering amount
$136.7M
Amount sold
$30M
First sale
May 2025
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedMar 2025 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew FedderExecutive Officer, Director
  • Adam FriedmanExecutive Officer, Director
  • Brian PiperExecutive Officer, Director
Offering amount
$40M
Amount sold
$40M
First sale
Mar 2025
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Antares Therapeutics - Lightspeed Venture Partnerslsvp.com · Jun 2025Antares Therapeutics gains $177m for cancer medicines developmentfinance.yahoo.com · Jun 2025Antares Therapeutics Raises $177M in Series A Fundingfinsmes.com · Jun 2025Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases - BioSpacebiospace.com · Jun 2025Scorpion spinout Antares raises $177M for preclinical portfoliofiercebiotech.com · Jun 2025Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseasesbusinesswire.com · Jun 2025

Frequently asked questions

Who are Antares Therapeutics's investors?
Antares Therapeutics's investors include Tenmile, Abingworth, Atlas Venture, Biotechnology Value Fund, Lightspeed Venture Partners, Vida Ventures.
How much funding has Antares Therapeutics raised?
Antares Therapeutics has disclosed $70M raised across 2 rounds.
Where is Antares Therapeutics headquartered?
Antares Therapeutics is headquartered in Boston, US.